gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
First non-invasive vagus nerve stimulation therapy applied at the neck provides new option for Americans living with migraine
BASKING RIDGE, N.J., Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- electroCore, LLC (electroCore), a commercial-s... Devices, Neurology, FDA gammaCore, vagus nerve, neuromodulation, migraine, cluster headache
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Headache | Marketing | Migraine | Neurology | Pain | Pharmaceuticals | Vagus Nerve Stimulation Therapy